Year |
Citation |
Score |
2020 |
Liu Y, Moore JH, Kolling GL, McGrath JS, Papin JA, Swami NS. Minimum Bactericidal Concentration of Ciprofloxacin to Determined Rapidly Based on Pyocyanin Secretion. Sensors and Actuators. B, Chemical. 312. PMID 32606491 DOI: 10.1016/J.Snb.2020.127936 |
0.337 |
|
2020 |
Moore JH, Honrado C, Stagnaro V, Kolling G, Warren CA, Swami NS. Rapid assessment of inhibition by probiotics using dielectrophoresis to quantify cell structure alterations. Acs Infectious Diseases. PMID 32239920 DOI: 10.1021/Acsinfecdis.9B00415 |
0.344 |
|
2018 |
Bartelt LA, Bolick DT, Kolling GL, Stebbins E, Huston CD, Guerrant RL, Hoffman PS. Amixicile reduces severity of cryptosporidiosis, but does not have activity against . Antimicrobial Agents and Chemotherapy. PMID 30297368 DOI: 10.1128/Aac.00718-18 |
0.312 |
|
2018 |
Giallourou N, Medlock GL, Bolick DT, Medeiros PH, Ledwaba SE, Kolling GL, Tung K, Guerry P, Swann JR, Guerrant RL. A novel mouse model of Campylobacter jejuni enteropathy and diarrhea. Plos Pathogens. 14: e1007083. PMID 29791507 DOI: 10.1371/Journal.Ppat.1007083 |
0.374 |
|
2018 |
Borgersen Q, Bolick DT, Kolling GL, Aijuka M, Ruiz-Perez F, Guerrant RL, Nataro JP, Santiago AE. Abundant production of Exopolysaccharide by EAEC strains enhances the formation of bacterial biofilms in contaminated sprouts. Gut Microbes. 0. PMID 29543544 DOI: 10.1080/19490976.2018.1429877 |
0.306 |
|
2017 |
Shin JH, Gao Y, Moore JH, Bolick DT, Kolling GL, Wu M, Warren CA. Innate immune response and outcome of Clostridium difficile infection are dependent on fecal bacterial composition in the aged host. The Journal of Infectious Diseases. PMID 28968660 DOI: 10.1093/Infdis/Jix414 |
0.354 |
|
2017 |
Bartelt LA, Bolick DT, Mayneris-Perxachs J, Kolling GL, Medlock GL, Zaenker EI, Donowitz J, Thomas-Beckett RV, Rogala A, Carroll IM, Singer SM, Papin J, Swann JR, Guerrant RL. Cross-modulation of pathogen-specific pathways enhances malnutrition during enteric co-infection with Giardia lamblia and enteroaggregative Escherichia coli. Plos Pathogens. 13: e1006471. PMID 28750066 DOI: 10.1371/Journal.Ppat.1006471 |
0.417 |
|
2017 |
Bolick DT, Mayneris-Perxachs J, Medlock GL, Kolling GL, Papin J, Swann JR, Guerrant RL. Increased urinary trimethylamine N-oxide (TMAO) following Cryptosporidium infection and protein malnutrition independent of microbiome effects. The Journal of Infectious Diseases. PMID 28520899 DOI: 10.1093/Infdis/Jix234 |
0.384 |
|
2016 |
Biggs MB, Medlock GL, Moutinho TJ, Lees HJ, Swann JR, Kolling GL, Papin JA. Systems-level metabolism of the altered Schaedler flora, a complete gut microbiota. The Isme Journal. PMID 27824342 DOI: 10.1038/Ismej.2016.130 |
0.301 |
|
2016 |
Liu J, Bolick DT, Kolling GL, Fu Z, Guerrant RL. Protein malnutrition impairs intestinal epithelial turnover: a potential mechanism of increased cryptosporidiosis in a murine model. Infection and Immunity. PMID 27736783 DOI: 10.1128/Iai.00705-16 |
0.35 |
|
2016 |
Mayneris-Perxachs J, Bolick DT, Leng J, Medlock GL, Kolling GL, Papin JA, Swann JR, Guerrant RL. Protein- and zinc-deficient diets modulate the murine microbiome and metabolic phenotype. The American Journal of Clinical Nutrition. PMID 27733402 DOI: 10.3945/Ajcn.116.131797 |
0.315 |
|
2016 |
Oriá RB, Murray-Kolb LE, Scharf RJ, Pendergast LL, Lang DR, Kolling GL, Guerrant RL. Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children. Nutrition Reviews. PMID 27142301 DOI: 10.1093/Nutrit/Nuw008 |
0.329 |
|
2016 |
van Opstal E, Kolling GL, Moore JH, Coquery CM, Wade NS, Loo WM, Bolick DT, Shin JH, Erickson LD, Warren CA. Vancomycin treatment alters humoral immunity and intestinal microbiota in an aged mouse model of Clostridium difficile infection. The Journal of Infectious Diseases. PMID 26917573 DOI: 10.1093/Infdis/Jiw071 |
0.356 |
|
2016 |
Moore JH, van Opstal E, Kolling GL, Shin JH, Bogatcheva E, Nikonenko B, Einck L, Phipps AJ, Guerrant RL, Protopopova M, Warren CA. Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model. The Journal of Antimicrobial Chemotherapy. PMID 26832756 DOI: 10.1093/Jac/Dkv479 |
0.31 |
|
2015 |
Moore JH, Pinheiro CC, Zaenker EI, Bolick DT, Kolling GL, van Opstal E, Noronha FJ, De Medeiros PH, Rodriguez RS, Lima AA, Guerrant RL, Warren CA. Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model. Plos One. 10: e0131829. PMID 26181795 DOI: 10.1371/Journal.Pone.0131829 |
0.356 |
|
2015 |
Obata F, Subrahmanyam PB, Vozenilek AE, Hippler LM, Jeffers T, Tongsuk M, Tiper I, Saha P, Jandhyala DM, Kolling GL, Latinovic O, Webb TJ. Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice. Frontiers in Microbiology. 6: 262. PMID 25904903 DOI: 10.3389/Fmicb.2015.00262 |
0.319 |
|
2015 |
Doran A, Vance S, Warren C, Kolling G, Chaplain A, Archbald-Pannone L, Behm B, Hays AR. Microscopic Colitis in Recurrent C. difficile Infection May Resolve Spontaneously After FMT American Journal of Gastroenterology. 110: S584. DOI: 10.14309/00000434-201510001-01340 |
0.31 |
|
2015 |
Shin JH, Moore J, Bolick D, Kolling G, Warren C. Poor Disease Outcome From Clostridium difficile Infection in the Aged Host: Role of Impaired Innate Immunity and Altered Intestinal Microbiota in a Mouse Model Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.582 |
0.338 |
|
2014 |
Bolick DT, Kolling GL, Moore JH, de Oliveira LA, Tung K, Philipson C, Viladomiu M, Hontecillas R, Bassaganya-Riera J, Guerrant RL. Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative escherichia coli-induced diarrhea. Gut Microbes. 5: 618-27. PMID 25483331 DOI: 10.4161/19490976.2014.969642 |
0.376 |
|
2014 |
Madan R, Guo X, Naylor C, Buonomo EL, Mackay D, Noor Z, Concannon P, Scully KW, Pramoonjago P, Kolling GL, Warren CA, Duggal P, Petri WA. Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis. Infection and Immunity. 82: 341-9. PMID 24166957 DOI: 10.1128/Iai.00972-13 |
0.344 |
|
2013 |
Amran MY, Fujii J, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S. Proposal for effective treatment of Shiga toxin-producing Escherichia coli infection in mice. Microbial Pathogenesis. 65: 57-62. PMID 24120399 DOI: 10.1016/J.Micpath.2013.09.008 |
0.384 |
|
2013 |
Medeiros P, Bolick DT, Roche JK, Noronha F, Pinheiro C, Kolling GL, Lima A, Guerrant RL. The micronutrient zinc inhibits EAEC strain 042 adherence, biofilm formation, virulence gene expression, and epithelial cytokine responses benefiting the infected host. Virulence. 4: 624-33. PMID 23958904 DOI: 10.4161/Viru.26120 |
0.381 |
|
2013 |
D'Auria KM, Kolling GL, Donato GM, Warren CA, Gray MC, Hewlett EL, Papin JA. In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B. Infection and Immunity. 81: 3814-24. PMID 23897615 DOI: 10.1128/Iai.00869-13 |
0.353 |
|
2013 |
Bartelt LA, Roche J, Kolling G, Bolick D, Noronha F, Naylor C, Hoffman P, Warren C, Singer S, Guerrant R. Persistent G. lamblia impairs growth in a murine malnutrition model. The Journal of Clinical Investigation. 123: 2672-84. PMID 23728173 DOI: 10.1172/Jci67294 |
0.335 |
|
2013 |
Amran MY, Fujii J, Suzuki SO, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S. Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice. Plos One. 8: e58959. PMID 23516588 DOI: 10.1371/Journal.Pone.0058959 |
0.37 |
|
2013 |
Rodrigues RS, Oliveira RA, Li Y, Zaja-Milatovic S, Costa LB, Braga Neto MB, Kolling GL, Lima AA, Guerrant RL, Warren CA. Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment. The Journal of Infectious Diseases. 207: 1505-15. PMID 23359592 DOI: 10.1093/Infdis/Jit041 |
0.392 |
|
2013 |
Warren CA, van Opstal EJ, Riggins MS, Li Y, Moore JH, Kolling GL, Guerrant RL, Hoffman PS. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice. Antimicrobial Agents and Chemotherapy. 57: 689-96. PMID 23147742 DOI: 10.1128/Aac.00877-12 |
0.366 |
|
2012 |
Li Y, Figler RA, Kolling G, Bracken TC, Rieger J, Stevenson RW, Linden J, Guerrant RL, Warren CA. Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment. Bmc Infectious Diseases. 12: 342. PMID 23217055 DOI: 10.1186/1471-2334-12-342 |
0.356 |
|
2012 |
Kolling G, Wu M, Guerrant RL. Enteric pathogens through life stages. Frontiers in Cellular and Infection Microbiology. 2: 114. PMID 22937528 DOI: 10.3389/Fcimb.2012.00114 |
0.344 |
|
2012 |
Kolling GL, Wu M, Warren CA, Durmaz E, Klaenhammer TR, Timko MP, Guerrant RL. Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production. Gut Microbes. 3: 523-9. PMID 22895082 DOI: 10.4161/Gmic.21757 |
0.393 |
|
2012 |
Warren CA, van Opstal E, Ballard TE, Kennedy A, Wang X, Riggins M, Olekhnovich I, Warthan M, Kolling GL, Guerrant RL, Macdonald TL, Hoffman PS. Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model. Antimicrobial Agents and Chemotherapy. 56: 4103-11. PMID 22585229 DOI: 10.1128/Aac.00360-12 |
0.341 |
|
2012 |
D'Auria KM, Donato GM, Gray MC, Kolling GL, Warren CA, Cave LM, Solga MD, Lannigan JA, Papin JA, Hewlett EL. Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control. Bmc Systems Biology. 6: 2. PMID 22225989 DOI: 10.1186/1752-0509-6-2 |
0.338 |
|
2011 |
Pawlowski SW, Calabrese G, Kolling GL, Platts-Mills J, Freire R, Warren CA, Liu B, Sartor RB, Guerrant RL. Erratum: Murine model of Clostridium difficile infection (CDI) using aged gnotobiotic C57BL/6 mice and a BI strain (Journal of Infectious Diseases (2010) 202:11 (1708-1712)) The Journal of Infectious Diseases. 203. DOI: 10.1093/Infdis/Jir055 |
0.332 |
|
2010 |
Pawlowski SW, Calabrese G, Kolling GL, Freire R, Alcantara Warren C, Liu B, Sartor RB, Guerrant RL. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain Journal of Infectious Diseases. 202: 1708-1712. PMID 20977342 DOI: 10.1086/657086 |
0.361 |
|
2009 |
Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infection and Immunity. 77: 959-69. PMID 19124603 DOI: 10.1128/Iai.00679-08 |
0.313 |
|
2007 |
Kolling GL, Matthews KR. Influence of enteric bacteria conditioned media on recovery of Escherichia coli O157:H7 exposed to starvation and sodium hypochlorite. Journal of Applied Microbiology. 103: 1435-41. PMID 17953554 DOI: 10.1111/J.1365-2672.2007.03377.X |
0.528 |
|
2003 |
Li J, Kolling GL, Matthews KR, Chikindas ML. Cold and carbon dioxide used as multi-hurdle preservation do not induce appearance of viable but non-culturable Listeria monocytogenes. Journal of Applied Microbiology. 94: 48-53. PMID 12492922 DOI: 10.1046/J.1365-2672.2003.01795.X |
0.488 |
|
2001 |
Kolling GL, Matthews KR. Examination of recovery in vitro and in vivo of nonculturable Escherichia coli O157:H7. Applied and Environmental Microbiology. 67: 3928-33. PMID 11525987 DOI: 10.1128/Aem.67.9.3928-3933.2001 |
0.56 |
|
2000 |
Yaron S, Kolling GL, Simon L, Matthews KR. Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Applied and Environmental Microbiology. 66: 4414-20. PMID 11010892 DOI: 10.1128/Aem.66.10.4414-4420.2000 |
0.543 |
|
1999 |
Kolling GL, Matthews KR. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Applied and Environmental Microbiology. 65: 1843-8. PMID 10223967 DOI: 10.1128/Aem.65.5.1843-1848.1999 |
0.521 |
|
Show low-probability matches. |